Ethical Considerations in the Conduct of Clinical Pharmacokinetic Studies
- 1 October 1989
- journal article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 17 (4) , 217-222
- https://doi.org/10.2165/00003088-198917040-00001
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Is blood sampling for determination of antipyrine pharmacokinetics in healthy volunteers ethically justified?Clinical Pharmacology & Therapeutics, 1988
- Ethics of drug studies in infants: How many samples are required for accurate estimation of pharmacokinetic parameters in neonates?The Journal of Pediatrics, 1987
- Vancomycin dosing in preterm infants: Prospective verification of new recommendationsThe Journal of Pediatrics, 1987
- Vancomycin pharmacokinetics and dose recommendations for preterm infantsAntimicrobial Agents and Chemotherapy, 1987
- Measurement of antipyrine half‐life from urinary drug concentrations [letter]British Journal of Clinical Pharmacology, 1984
- Anterior interosseous nerve syndrome: unusual etiologies.1983
- Underrepresentation of Women in New Drug TrialsAnnals of Internal Medicine, 1981
- SINGLE POINT CLEARANCE ESTIMATION1979
- Assessment of antipyrine kinetics by measurement in saliva.British Journal of Clinical Pharmacology, 1976
- Studies on the disposition of antipyrine, aminopyrine, and phenacetin using plasma, saliva, and urineClinical Pharmacology & Therapeutics, 1975